GLUTAMIC PYRUVIC TRANSAMINASE (GPT OR ALT) - ANVISA Registration 80657030027
Access comprehensive regulatory information for GLUTAMIC PYRUVIC TRANSAMINASE (GPT OR ALT) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80657030027 and manufactured by DAILYTECH LATINO AMERICA LTDA. The registration is held by DAILYTECH LATINO AMERICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80657030027
25351147730202408
03611875000118
Company Information
Dates and Status
Apr 15, 2024
VIGENTE
09/18/2025 19:00:01
TRANSAMINASE GLUTÂMICA PIRÚVICA (TGP OU ALT)
FAMÍLIA TGP/ALT
KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA
10377390287
Feb 17, 2025
TRANSAMINASE GLUTÂMICA PIRÚVICA (TGP OU ALT)
ALT Simplex
TASCOM CO., LTD
80074330015
Jan 27, 2025
TRANSAMINASE GLUTÂMICA PIRÚVICA (TGP OU ALT)
ALT/GPT 4+1 SL
DAILYTECH LATINO AMERICA LTDA
80657030045
Dec 23, 2024
TRANSAMINASE GLUTÂMICA PIRÚVICA (TGP OU ALT)
Volt TGP
HI TECHNOLOGIES LTDA
80583710042
Jul 03, 2023
TRANSAMINASE GLUTÂMICA PIRÚVICA (TGP OU ALT)
Imuchem ALT POC
TASCOM CO., LTD
80885650076
May 29, 2023

